SANOFI
SANOFI (France) consolidates 5 companies, according to the LEI register.
The sums add up the annual accounts of 5 of the 5 Belgian companies (financial years 2025), without consolidation.
Group risk
- No bankruptcy, liquidation, negative equity or overdue accounts among the Belgian companies.
Group structure
Per company: the verdict from its dossier, the total assets with the equity under them, and the financial year of those accounts. High risk Elevated Fair Healthy No verdict
- SANOFI5 subsidiaries
- Healthy · 96€417.3m €359.2m 2025
- Healthy · 97€1.00bn €862.1m 2025
- Healthy · 81€32.3m €20.7m 2025
- Healthy · 83€218.9m €87.2m 2025
- No verdict€5.1m €612,658 2025
Your exposure to this group
Sign in to see which customers or suppliers from your lists belong to this group, and how they stand.
Group insights
A weak subsidiary can cost the parent money, and the other way round.
- 59.8% of the added-up total assets sits in one company: GENZYME FLANDERS.
- None of the added-up total assets sits at a company with an elevated or high risk.
Method and sources
The group's make-up comes from the LEI register (GLEIF). It states which company consolidates which other, directly or ultimately.
A company stands under its parent if the parent consolidates it according to the LEI register. The parent then takes the subsidiary into its group accounts and controls it.
The amounts come from the annual accounts each Belgian company filed with the National Bank. They are added up without consolidation. Receivables, participations and sales between group companies therefore count. The verdict per company is that of its dossier.
Updated on 01-11-2026